36C25925Q0267.docx

DOCX document 4 MB Posted Mar 10, 2025

Attached to: Q301--Unrestricted- Immunohistological Stains Reference Testing for Rocky Mountain Regional VA Medical Center
Solicitation number: 36C25925Q0267
Issued by: Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19

About this file

Written by GovTribe AI · Mar 10, 2025

This document is a federal solicitation (Request for Quote) for immunohistochemical, special stain, and reference laboratory testing services for the Rocky Mountain Regional VA Medical Center. The solicitation (36C25925Q0267) is an unrestricted procurement seeking a Blanket Purchase Agreement (BPA) for medical laboratory services, with a five-year performance period from July 1, 2025, through June 30, 2030, and a total estimated value of $41.5 million.

The contractor will be required to provide comprehensive laboratory testing including immunohistochemical stains, molecular testing, genetic analysis, and specialized cancer-related diagnostics. Key requirements include being CLIA and CAP certified, performing all tests in-house without subcontracting, maintaining strict turnaround times (2-5 days for most tests), and offering a wide range of testing services covering multiple cancer types and diagnostic markers. Quotes are due by 4:30 PM Mountain Time on March 28th, with evaluation criteria including technical capability, past performance, and pricing, with technical and past performance considered more important than price.

View the file

Other files

File	Type	Posted
36C25925Q0267 0002.docx	DOCX document	Apr 14, 2025
36C25925Q0267 0001.docx	DOCX document	Mar 28, 2025
Attachment B - Amendment 0001 Questions and Answers.docx	DOCX document	Mar 28, 2025
Attachment A - CPT Codes.xlsx	XLSX spreadsheet	Mar 28, 2025

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

36C25925Q0267

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE

DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a.

PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

UEI:

EFT:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE

ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA

26.

TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C259-25-AP-0056

36C25925Q0267 03-10-2025 Karly Morris 405-456-5840 03-28-2025 16:30

MDT

36C259 Department of Veterans Affairs Network Contracting Office

NCO 19

6162 South Willow Drive, Suite 300 Greenwood Village CO 80111 X 621511 $41.5 Million N/A X Department of Veterans Affairs Rocky Mountain Regional VA Medical Center 1700 N Wheeling St.

Aurora, CO 80045 36C259 Department of Veterans Affairs Network Contracting Office

NCO 19

6162 South Willow Drive, Suite 300 Greenwood Village CO 80111

Submitted Electronically Department of Veterans Affairs Financial Service Center PO Box 149971 Austin TX 78714-9971 See CONTINUATION Page Contractor shall provide Immunohistochemical, Special Stain, Hematopathology, Genetic, Molecular, and Solid Tumor Reference Laboratory Services for the Rocky Mountain Regional VA Medical Center under a five-year Blanket Purchase Agreement (BPA) per Statement of Work.

Review and follow the Addendum to FAR 52.212-1, Instructions to Offerors - Commercial Items & Addendum to FAR 52.212-2 Evaluation - Commercial Items.

See CONTINUATION Page X X Lindsey Zwaagstra

VA-VHA-RPOW-2025-0014

Table of Contents

SECTION A	1
A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES	1
SECTION B - CONTINUATION OF SF 1449 BLOCKS	4
B.1 CONTRACT ADMINISTRATION DATA	4
B.2 STATEMENT OF WORK	6
B.3 PRICE/COST SCHEDULE	15
ITEM INFORMATION	15
B.4 BPA INTRODUCTION	80
B.5 BPA TERMS AND CONDITIONS	80
B.6 BPA ADMINISTRATIVE DATA	80
B.7 BPA PRICING DATA	80
B.8 OPTION TO EXTEND THE TERM OF THE BPA	81
B.9 AUTHORIZED LIMITS	81
B.10 OBLIGATION OF FUNDS	81
B.11 PERIOD OF PERFORMANCE	81
B.12 AUTHORIZED INDIVIDUALS	82
B.13 ORDER FORMAT	82
B.14 AUTHORIZED REPRESENTATIVES	82
B.15 FEDERAL HOLIDAYS	82
B.16 INVOICES	82
B.17 PRECEDENCE	83
SECTION C - CONTRACT CLAUSES	84
C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (NOV 2023)	84
C.2 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)	89
C.3 52.227-14 RIGHTS IN DATA—GENERAL (MAY 2014)	90
C.4 52.232-19 AVAILABILITY OF FUNDS FOR THE NEXT FISCAL YEAR (APR 1984)	95
C.5 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018)	95
C.6 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020)	96
C.7 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)	97
C.8 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)	97
C.9 VAAR 852.215-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-OWNED SMALL BUSINESS EVALUATION FACTORS (JAN 2023) (DEVIATION)	97
C.10 VAAR 852.215-71 EVALUATION FACTOR COMMITMENTS (OCT 2019)	98
C.11 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (JAN 2025)	98
SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS	108
D.1 WAGE DETERMINATIONS	109
SECTION E - SOLICITATION PROVISIONS	120
E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (SEP 2023)	120
E.2 52.201-1 ACQUISITION 360: VOLUNTARY SURVEY (SEP 2023)	125
E.3 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)	126
E.4 52.204-29 FEDERAL ACQUISITION SUPPLY CHAIN SECURITY ACT ORDERS—REPRESENTATION AND DISCLOSURES (DEC 2023)	128
E.5 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)	130
E.6 52.233-2 SERVICE OF PROTEST (SEP 2006)	131
E.7 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION (OCT 2018)	131
E.8 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)	132
E.9 VAAR 852.209-70 ORGANIZATIONAL CONFLICTS OF INTEREST (OCT 2020)	133
E.10 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998)	133
E.11 VAAR 852.215-72 NOTICE OF INTENT TO RE-SOLICIT (OCT 2019)	134
E.12 VAAR 852.252-70 SOLICITATION PROVISIONS OR CLAUSES INCORPORATED BY REFERENCE (JAN 2008)	134
E.13 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (NOV 2021)	134
E.14 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (MAY 2024)	136

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.1 CONTRACT ADMINISTRATION

(continuation from Standard Form 1449, block 18A.)

B.1.1. Contract Administration: All contract administration matters will be handled by the following individuals:

B.1.1.1. CONTRACTOR: Name:

Company:

Address:

Telephone#:

FAX #:

E-mail address:

B.1.1.2. GOVERNMENT: Karly Morris, Contract Specialist Department of Veterans Affairs Rocky Mountain Network NCO 19 Contracting 6162 S. Willow Drive, Suite 300 Greenwood Village, CO 80111 Telephone: (405) 456-5840 E-mail: Karly.Morris@va.gov NCO19LAB@va.gov

B.1.2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer - System for Award Management (SAM), or

[N/A] 52.232-36, Payment by Third Party

B.1.3. GOVERNMENT INVOICE ADDRESS: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] MONTHLY IN ARREARS

B.1.4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests. All invoices from the contractor shall be submitted electronically to the VA Financial Services Center for payment processing, free of charge. For any questions about the e-invoicing program, please contact the FSC at the phone number or email address listed below:

• OB10/Tungsten e-Invoice Setup Information: (877) 752-0900

• OB10/Tungsten e-Invoice email: USClientServices@ob10.com

• FSC e-Invoice Contact Information: (877) 353-9791

• FSC e-invoice email: vafsccshd@va.gov

• The following two codes will be required when creating a vendor profile in OB10:

OB10 Buyer Number AAA544240062 Promo Code: VAPC7Y18

B.1.5. DUNS NUMBER: Please provide the Dun and Bradstreet Number assigned to your firm in the space provided:

B.1.6. CONTRACTOR’S UNIQUE ENTITY ID (SAM): Please provide your firms Unique Entity DI:

B.1.7. TAX IDENTIFICATION NUMBER: Please provide the tax identification number to be utilized for this contract:

B.1.8. PERIOD OF PERFORMANCE: Services required herein shall be for the following time period:

36C25925Q0267 Period of Performance: July 1, 2025 through June 30, 2030.

Page 1 of Page 1 of

B.2 STATEMENT OF WORK

Rocky Mountain Regional VAMC Immunohistochemical, Special Stain, Hematopathology, Genetic, Molecular, & Solid Tumor Reference Laboratory Services Statement of Work

1. SCOPE:

The Contractor should be able to provide a wide range of testing services as well as specialized laboratory testing including but not limited to immunohistochemical stains, special stains, diagnostic and prognostic markers for breast cancer prognosis to include interpretation, IHC breast assays, HER2 Profiling, Micrometastasis analysis, gastric cancer profile, molecular PCR pathway testing, mismatch repair (MMR/microsatellite instability (MSI), diagnostic and prognostic molecular testing for all types of malignancy and other specialty testing, on a cost per test basis. See Test Schedule (Attachment A: Minimum Tests Required) for the minimum test list. This list is not all inclusive. Rocky Mountain Regional VA Medical Center (RMRVAMC) reserves the right to order any test provided by the Contractor.

2. GENERAL REQUIREMENTS:

A. In-house Testing

a. The Contractor shall have the ability to perform all testing listed without splitting the specimen and sending to subcontracted labs as these are irretrievable specimens from surgical/invasive procedures and cannot be recollected.

b. The Contractor shall perform all tests listed in house without sending tests out to a subcontractor as these are irretrievable specimens from surgical/invasive procedures and cannot be recollected in order to minimize loss, errors, and degradation of samples. Sample integrity shall be ensured by all tests being performed in house.

B. Turnaround Time

a. The Contractor shall have 2-5 days maximum from time of receipt to return stains to the Government for review by RMRVAMC pathologists.

b. The Contractor shall have 7-14 days maximum from time of receipt to return molecular testing, global testing, and specialized testing to the Government.

c. The Contractor shall have 2-3 days maximum from time of receipt to return a FAXED report of the diagnostic test results to RMRVAMC Pathology Department.

d. The Contractor shall have 2-5 days maximum from time of receipt of Government provided patient stains and specimens, to ship back/return patient stains/slides and molecular specimens (once testing is complete) to RMRVAMC Pathology Department.

C. Performance Measures

a. The Government will monitor the accuracy of invoices and quality of reports in relation to the clinical history for the patient.

b. The Contractor’s performance will be monitored on the following criteria:

i. No more than 5% of tests sent are falsely negative or falsely positive

ii. Contractor cannot request additional testing material in more than 10% of all cases sent

iii. Contractor cannot exceed defined Turnaround times in more than 10% of all cases sent D. Ordering Paper requisitions shall be provided by the Contractor. The Government will utilize the paper requisitions and check off tests needed for the specimen(s). The Government will send/ship the paper requisition/form along with the specimen(s) to the Contractor.

E. Prices and Terms The Contractor shall provide pricing for available in-house tests in accordance with Cost per Test (CPT) contained in the Test Schedule (Attachment A: Required Tests). RMRVAMC will provide an annual test volume. The values are estimated. Attachment A is not an all-inclusive list, but the minimal tests the Contractor provides. RMRVAMC reserves the right to order any test provided by the Contractor. Newly developed testing shall be added as required/needed. Any additional costs such as Industrial Funding Fees, special shipping and handling fees, or other usage fees must be clearly indicated in the price quote.

F. Resources

a. Government Furnished Resources

i. The Government shall package the specimens (tissue and cytology specimens) in packaging and shipping materials provided by the Government and ship the package to the Contractor.

ii. There will be no shipping costs to the Contractor for specimens shipped to the Contractor for testing.

b. Contractor Funded Resources

i. Contractor shall ship back the specimens (for stains and molecular tests) and slides (from the stains) in Contractor furnished packaging and shipping material.

ii. Shipping costs for sending specimens and slides back to the Government will be the sole responsibility of the Contractor.

3. TECHNICAL REQUIEMENTS

A. The Contractor must be Clinical Laboratory Improvement Act (CLIA) and College of American Pathologists (CAP) certified. The Contractor shall provide a copy of their CLIA number when sending their proposals to the solicitation.

B. The Contractor must have the required tests available with accompanying Current Procedural Terminology (CPT) codes. Each laboratory test must have defined turnaround times, defined specimen requirements, and defined specimen stability. These requirements should be available electronically.

C. The Contractor must have the ability to perform all testing listed without splitting the specimen.

D. These specimens are irretrievable as they are collected during invasive procedures.

E. The Contractor must have a system in place for the ordering of testing.

F. The Contractor shall have the ability to add new tests as they are developed/become available for the diagnosis of cancer.

G. The Contractor must perform the testing with sufficient quality of results as judged by the reviewing pathologist. Testing much correlate with clinical findings and other supportive diagnostic tests used to render a diagnosis.

H. The Contractor shall be HIPAA compliant.

Attachment A: Tests Required

· Mammostrat

· KRAS by PCR

· EGRF by PCR

· ALK FISH

· BRAF V600 Mutation

· BRAF by PCR

· EGRF by FISH

· MMR global

· Her 2 neu global

· Her 2 neu FISH

· ER global

· PR global

· MSI by PCR

· Kappa FISH (stain only)

· Lambda FISH (stain only) Immunostain:

· AACT

· AAT

· ACTH

· Actin (MSA)

· Actin (SMA)

· Adenovirus

· AE1/AE3 (pan-CK)

· AFP

· ALK-1

· Amyloid A

· AR

· ß-Amyloid P

· B72.3

· B-Amyloid

· BCA-225

· BCL1 (Cyclin D1)

· BCL6

· BCL2

· BerEP4

· Beta-Catenin

· BE-8, BOB1

· BRCA1

· Breast Triple Stain

· CA15.3

· CA19.9

· CA125

· Calcitonin

· Caldesmon

· Claponin

· Calretinin

· CAM 5.2

· Cathepsin D

· Cat Scratch

· Cyclin D1/BCL1

· CD1a

· CD2

· CD3

· CD4

· CD5

· CD7

· CD8

· CD10

· CD11c

· CD14

· CD15

· CD19

· CD20

· CD21

· CD22

· CD23

· CD25

· CD30

· CD31

· CD33

· CD34

· CD35

· CD38

· CD42b

· CD43

· CD45

· CD45RB

· CD45RO

· CD56

· CD57

· CD61

· CD68

· CD74

· CD75

· CD79a

· CD99

· CD117(C-KIT)

· CD123

· CD138

· CD163

· CDX2

· CDX2/CK7

· CEA monoclonal

· CEA polyclonal

· Chromogranin A

· CK5

· CK5/6

· CK7

· CK8

· CK14

· CK17

· CK18

· CK19

· CK20

· CK903(CK-HMW)

· CK-Double Stain (HMW/LMW)

· CK OSCAR (pan-CK)

· CMV

· Collagen IV

· COX2

· CXCR4

· Cyclin E

· D2-40

· DBA.44

· DCC

· Desmin

· DOG1

· DPC4 (SMADU)

· EBV(LMP-1)

· E-Cadherin

· eIFd4E

· EGFR

· EMA

· ER

· ERCC1

· Factor VIII

· Factor XIIIa

· Fascin

· Fli-1

· FOX P3

· FSH

· GCDFP-15

· GFAP

· GH

· Gastrin

· Glucagon

· GSTπ

· Glycophorin-A

· Glypican-3

· Granzyme

· H.Pylori

· HBVc

· HBVs

· HBME-1

· HER2(hercepTest)

· HCGβ

· Hemoglobin A

· HepPar-1

· HHV8

· HPV

· HLA-DR

· HMB-45

· HAFG2

· HPL

· HSV I

· HSV II

· IgA

· IgD

· IgG

· IgG4

· IgM

· Inhibin

· Insulin

· Kappa

· Ki-67

· Ki-67/Caspase-3

· LH

· Lambda

· Lysozyme

· Mammaglobin

· Melan A

· Mesothelin

· MGMT

· MITF

· MOC-31

· MSH2

· MSH6

· MDR

· MLH1

· M PO

· mTOR

· MUC-1

· MUC-2

· MUC-5

· MUC-6

· MUM1

· MyoD1

· Myogenin

· Myoglobin

· Napsin A

· NB

· NF

· NSE

· OCT 2

· OCT 4

· p16

· p21

· p27

· p53

· p57

· p63

· p120(caterin)

· p501S

· p504S

· Pakt

· Pan Melanoma

· Parvovirus

· PAX2

· PAX5

· PD1

· PDGFRA

· PDGFRB

· Perforin

· PHH3

· PLAB

· P.Carinii

· PMS2

· PP

· PR

· Prealbumin (TTR)

· Prolactin

· Prostate Triple Stain

· PSA

· PSAP/HPAP

· PTEN

· PTH

· RCC1

· S100

· Serotonin

· SMMHC

· Somatostatin

· Surfactant

· Spirochete

· Survivin

· Synaptophysin

· Tau

· TdT

· TM

· TGB

· TGF- α

· TRAP

· TS

· TSH

· TTF-1

· TIA-1

· Toxoplasma

· Tryptase

· Tuberculosis

· Tyrosinase

· Uroplakin III

· VEGF

· Villin

· Vimenti

· Wilm’s Tumor (WT-1)

· ZAP-70

Hematopathology:

· Flow Cytometry Panels

· FISH (Hematologic, Plasma Cell)

· Individual Probes

· Cytogenetics

· Molecular Genetic Testing

· Cancer Profiles

· Liquid Biopsy Testing Solid Tumor:

· Consultation

· Cancer Profiles

· Prostate Cancer Testing

· Breast Cancer Testing

· Colon Cancer

· Sarcoma

· Brain Cancer

· Bladder Cancer

· GI Cancer

· Melanoma

· Lung Cancer Page 1 of Page 1 of

(End of Statement of Work)

B.3 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM NUMBER

DESCRIPTION OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

1.00

__________________

Mammostrat Contract Period: Base POP Begin: 07-01-2025 POP End: 06-30-2030 PRINCIPAL NAICS CODE: 621511 - Medical Laboratories PRODUCT/SERVICE CODE: Q301 - Medical - Reference Laboratory Testing Not to exceed 10 tests annually

1.00

__________________

KRAS by PCR